Abstract
Objective: According to the Treatment Guidelines for Uterine Body Cancer by the Japan Society of Gynecologic Oncology, pelvic lymphadenectomy can be omitted in patients with endometrial adenocarcinoma G1 or G2, ≤1/2 myometrial invasion, and no findings of extrauterine lesion. We aimed to identify indications for omitting pelvic lymphadenectomy in selected cases by reviewing cases of total laparoscopic hysterectomy (TLH) for early-stage endometrial cancer retrospectively.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: JAPANESE JOURNAL OF GYNECOLOGIC AND OBSTETRIC ENDOSCOPY
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
